Self-palpation for detection of paroxysmal atrial fibrillation: Much noise with little signal


Autoři: Kazem Rahimi aff001;  Paulus Kirchhof aff003
Působiště autorů: Deep Medicine, Big Data Insitute, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom aff001;  NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom aff002;  Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom aff003;  Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany aff004;  SWBH and UHB NHS Trusts, Birmingham, United Kingdom aff005;  AFNET, Münster, Germany aff006
Vyšlo v časopise: Self-palpation for detection of paroxysmal atrial fibrillation: Much noise with little signal. PLoS Med 17(3): e32767. doi:10.1371/journal.pmed.1003098
Kategorie: Perspective
doi: 10.1371/journal.pmed.1003098

Souhrn

Kazem Rahimi and Paulus Kirchhof discuss the latest work from Faris Ghazal et al and how it may impact the way we currently detect Atrial Fibrillation in the general population.

Klíčová slova:

Atrial fibrillation – Cancer detection and diagnosis – Diagnostic medicine – Electrocardiography – Health screening – Heart – Medical devices and equipment – Patients


Zdroje

1. Emdin CA, Anderson SG, Salimi-Khorshidi G, Woodward M, MacMahon S, Dwyer T, et al. Usual blood pressure, atrial fibrillation and vascular risk: Evidence from 4.3 million adults. Int J Epidemiol. 2017;46(1): 162–172. doi: 10.1093/ije/dyw053 27143136

2. Jonas DE, Kahwati LC, Yun JDY, Cook Middleton J, Coker-Schwimmer M, Asher GN. Screening for atrial fibrillation with electrocardiography: Evidence report and systematic review for the US preventive services task force. JAMA. 2018;320(5):485–498. doi: 10.1001/jama.2018.4190 30088015

3. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for atrial fibrillation with electrocardiography: US preventive services task force recommendation statement. JAMA. 2018;320(5): 478–484. doi: 10.1001/jama.2018.10321 30088016

4. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardio-Thoracic Surg. 2016;50(5): e1–e88. doi: 10.1093/ejcts/ezw313

5. Ghazal, F, Theobald H, Rosenqvist M, Al-Khalili F. Validity of daily self-pulse palpation for atrial fibrillation screening in patients 65 years and older: A cross-sectional study.

6. Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, et al. Screening for Atrial Fibrillation. Circulation; 2017;135(19): 1851–1867. doi: 10.1161/CIRCULATIONAHA.116.026693 28483832

7. Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass Screening for Untreated Atrial Fibrillation. Circulation; 2015;131(25): 2176–2184. doi: 10.1161/CIRCULATIONAHA.114.014343 25910800

8. Yan BP, Lai HSL, Chan CKY, Au ACK, Freedman B, Poh YC, et al. High-throughput, contact-free detection of atrial fibrillation from video with deep learning: a proof-of-concept study. JAMA Cardiol. 2019;5(1): 1–7. doi: 10.1001/jamacardio.2019.4004 31774461

9. Attia ZI, Noseworthy PA, Lopez-Jimenez F, Asirvatham SJ, Deshmukh AJ, Gersh BJ, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet. 2019;394(10201): 861–867. doi: 10.1016/S0140-6736(19)31721-0 31378392

10. Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, et al. Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med. 2019;381: 1909–1917. doi: 10.1056/NEJMoa1901183 31722151

11. Healey JS, Alings M, Ha A, Leong-Sit P, Birnie DH, de Graaf JJ, et al. Subclinical Atrial Fibrillation in Older Patients. Circulation. 2017;136(14): 1276–1283. doi: 10.1161/CIRCULATIONAHA.117.028845 28778946

12. Bertaglia E, Blank B, Blomström-Lundqvist C, Brandes A, Cabanelas N, Dan GA, et al. Atrial high-rate episodes: Prevalence, stroke risk, implications for management, and clinical gaps in evidence. Europace. 2019;21(10): 1459–1467. doi: 10.1093/europace/euz172 31377792

13. Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362: k3519. doi: 10.1136/bmj.k3519 30185521

14. Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20): 1591–1602. doi: 10.1093/eurheartj/ehw007 26888184

15. Rahimi K. Subclinical atrial fibrillation in need of more assertive evidence. Eur Heart J. 2017;38(17): 1345–1347. doi: 10.1093/eurheartj/ehx122 28379323

16. Kirchhof P, Blank BF, Calvert M, Camm AJ, Chlouverakis G, Diener H-C, et al. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial. Am Heart J. 2017;190: 12–18. doi: 10.1016/j.ahj.2017.04.015 28760205

17. Lopes RD, Alings M, Connolly SJ, Beresh H, Granger CB, Mazuecos JB, et al. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. Am Heart J. 2017;189: 137–145. doi: 10.1016/j.ahj.2017.04.008 28625370

18. Engdahl J, Svennberg E, Friberg L, Al-Khalili F, Frykman V, Gudmundsdottir KK, et al. Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: The STROKESTOP II study design. Europace. 2017;19(2): 297–302. doi: 10.1093/europace/euw319 28011798


Článek vyšel v časopise

PLOS Medicine


2020 Číslo 3

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Imunitní trombocytopenie (ITP) u dospělých pacientů
nový kurz
Autoři: prof. MUDr. Tomáš Kozák, Ph.D., MBA

Pěnová skleroterapie
Autoři: MUDr. Marek Šlais

White paper - jak vidíme optimální péči o zubní náhrady
Autoři: MUDr. Jindřich Charvát, CSc.

Hemofilie - série kurzů

Faktory ovlivňující léčbu levotyroxinem
Autoři:

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

VIRTUÁLNÍ ČEKÁRNA ČR Jste praktický lékař nebo pediatr? Zapojte se! Jste praktik nebo pediatr? Zapojte se!

×